SEC Form 4 · accession 0001127602-15-023193
CVS HEALTH Corp · CVS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eva C Boratto
Officer — SVP, Cont & Chief Acct Officer
Period of report
Jul 19, 2015
Accepted (ET)
Jul 21, 2015 · 4:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000064803
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 19, 2015 | F | 6,661 | $110.14 | D | 24,301 | D | |
| Common Stock | Jul 20, 2015 | M | 22,107 | $30.16 | A | 46,408 | D | |
| Common StockF3 | Jul 20, 2015 | S | 22,107 | $110.3395 | D | 24,301 | D | |
| Common Stock (restricted) | holding | — | — | — | 22,872 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF4 | $30.16 | Jul 20, 2015 | M | 22,107 | D | Jul 19, 2013 | Jul 19, 2020 | Common Stock | 22,107 | 0 | D |
| Stock OptionF5 | $34.96 | holding | — | — | — | Apr 1, 2012 | Apr 1, 2018 | Common Stock | 6,029 | 6,029 | D |
| Stock OptionF6 | $45.07 | holding | — | — | — | Apr 2, 2013 | Apr 2, 2019 | Common Stock | 13,311 | 13,311 | D |
| Stock OptionF7 | $54.53 | holding | — | — | — | Apr 1, 2014 | Apr 1, 2020 | Common Stock | 13,278 | 13,278 | D |
| Stock OptionF8 | $74.29 | holding | — | — | — | Apr 1, 2015 | Apr 1, 2021 | Common Stock | 18,882 | 18,882 | D |
| Stock OptionF9 | $102.26 | holding | — | — | — | Apr 1, 2016 | Apr 1, 2022 | Common Stock | 27,392 | 27,392 | D |
Explanation of responses
- F1Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award.
- F2All sales were effected pursuant to a Rule 10b5-1 plan.
- F3Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $109.67 and $110.80 per share.
- F4Option became exercisable in three equal annual installments, commencing 7/19/2013.
- F5Option became exercisable in four equal annual installments, commencing 4/1/2012.
- F6Option became exercisable in four equal annual installments, commencing 4/2/2013.
- F7Option became exercisable in four equal annual installments, commencing 4/1/2014.
- F8Option became exercisable in four equal annual installments, commencing 4/1/2015.
- F9Option becomes exercisable in four equal annual installments, commencing 4/1/2016.